Brief: Orion, Abzena Announce Exclusive Commercial License For Abzena's Antibody
23/10/2025 13:31
Oct 23 (Reuters) - Orion Oyj ORNBV.HE: ORION AND ABZENA ANNOUNCE EXCLUSIVE COMMERCIAL LICENSE FOR ABZENA’S ANTIBODY Source text: ID:nGNE4FYm97 Further company coverage: ORNBV.HE (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))